Literature DB >> 18420466

An in silico immunological approach for prediction of CD8+ T cell epitopes of Leishmania major proteins in susceptible BALB/c and resistant C57BL/6 murine models of infection.

F Z Guerfali1, H Ben-Abdallah, R M Sghaier, K Ben-Aissa, G Mkannez, H Attia, D Laouini.   

Abstract

It is well established that MHC class II restricted-CD4 T cells are dominant during the development of immunity against Leishmania (L) in the C57BL/6-resistant mouse strain. However and in agreement with a number of previous observations indicating that specific CD8 T cells are primed during natural infection or vaccination in humans, a great deal of evidence obtained recently with the susceptible BALB/c murine model of infection by Leishmania major indicates that CD8 T cells participate in both pathogenesis and immunity to cutaneous leishmaniasis. Our goal herein was to identify in silico all parasitic peptides present in the whole L. major predicted proteome, using several public computational systems for the prediction of peptide binding to all MHC (histocompatibility complex-2) molecules in BALB/c and C57BL/6 mice (Syfpeithi, Rankpep, PRED(BALB/c) and Bimas). Peptides that were predicted to bind to different H2 molecules were then analysed for their homology with any of the murine proteins annotated so far, using the BLAST algorithm. Sets of selected peptides for each H2 molecule were defined by different prediction systems and compared to each other. Surprisingly, the results showed that a higher number of L. major peptides were predicted to bind H2 BALB/c molecules and very few or none to bind H2 C57BL/6 molecules. Our finding illustrates how a hybrid immuno-computational approach may be useful for biologists to target an in silico set of selected proteins to define potential candidate antigens for experimental vaccination with greater accuracy as well as a reduced number of T cell antigens.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18420466     DOI: 10.1016/j.meegid.2008.02.011

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  11 in total

1.  In silico identification of epitopes in Mycobacterium avium subsp. paratuberculosis proteins that were upregulated under stress conditions.

Authors:  Ratna B Gurung; Auriol C Purdie; Douglas J Begg; Richard J Whittington
Journal:  Clin Vaccine Immunol       Date:  2012-04-11

2.  Prediction and identification of mouse cytotoxic T lymphocyte epitopes in Ebola virus glycoproteins.

Authors:  Shipo Wu; Ting Yu; Xiaohong Song; Shaoqiong Yi; Lihua Hou; Wei Chen
Journal:  Virol J       Date:  2012-06-13       Impact factor: 4.099

3.  In silico analysis of six known Leishmania major antigens and in vitro evaluation of specific epitopes eliciting HLA-A2 restricted CD8 T cell response.

Authors:  Negar Seyed; Farnaz Zahedifard; Shima Safaiyan; Elham Gholami; Fatemeh Doustdari; Kayhan Azadmanesh; Maryam Mirzaei; Nasir Saeedi Eslami; Akbar Khadem Sadegh; Ali Eslami Far; Iraj Sharifi; Sima Rafati
Journal:  PLoS Negl Trop Dis       Date:  2011-09-06

4.  In silico predicted epitopes from the COOH-terminal extension of cysteine proteinase B inducing distinct immune responses during Leishmania (Leishmania) amazonensis experimental murine infection.

Authors:  Bernardo A S Pereira; Franklin S Silva; Karina M Rebello; Marcel Marín-Villa; Yara M Traub-Cseko; Thereza C B Andrade; Álvaro L Bertho; Ernesto R Caffarena; Carlos R Alves
Journal:  BMC Immunol       Date:  2011-08-08       Impact factor: 3.615

5.  Prediction of CD8+ Epitopes in Leishmania braziliensis Proteins Using EPIBOT: In Silico Search and In Vivo Validation.

Authors:  Angelo Duarte; Artur T L Queiroz; Rafael Tosta; Augusto M Carvalho; Carlos Henrique Barbosa; Maria Bellio; Camila I de Oliveira; Manoel Barral-Netto
Journal:  PLoS One       Date:  2015-04-23       Impact factor: 3.240

6.  Experimental Validation of Multi-Epitope Peptides Including Promising MHC Class I- and II-Restricted Epitopes of Four Known Leishmania infantum Proteins.

Authors:  Maria Agallou; Evita Athanasiou; Olga Koutsoni; Eleni Dotsika; Evdokia Karagouni
Journal:  Front Immunol       Date:  2014-06-10       Impact factor: 7.561

7.  CD8(+) T cells in leishmania infections: friends or foes?

Authors:  Simona Stäger; Sima Rafati
Journal:  Front Immunol       Date:  2012-01-24       Impact factor: 7.561

Review 8.  Post-Genomics and Vaccine Improvement for Leishmania.

Authors:  Negar Seyed; Tahereh Taheri; Sima Rafati
Journal:  Front Microbiol       Date:  2016-04-06       Impact factor: 5.640

9.  Combination of In Silico Methods in the Search for Potential CD4(+) and CD8(+) T Cell Epitopes in the Proteome of Leishmania braziliensis.

Authors:  Rafael de Freitas E Silva; Luiz Felipe Gomes Rebello Ferreira; Marcelo Zaldini Hernandes; Maria Edileuza Felinto de Brito; Beatriz Coutinho de Oliveira; Ailton Alvaro da Silva; Osvaldo Pompílio de-Melo-Neto; Antônio Mauro Rezende; Valéria Rêgo Alves Pereira
Journal:  Front Immunol       Date:  2016-08-29       Impact factor: 7.561

10.  Immunoproteomic identification of MbovP579, a promising diagnostic biomarker for serological detection of Mycoplasma bovis infection.

Authors:  Farhan Anwar Khan; Muhammad Faisal; Jin Chao; Kai Liu; Xi Chen; Gang Zhao; Harish Menghwar; Hui Zhang; Xifang Zhu; Muhammad Asif Rasheed; Chenfei He; Changmin Hu; Yingyu Chen; Eric Baranowski; Huanchun Chen; Aizhen Guo
Journal:  Oncotarget       Date:  2016-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.